drugset / Trial / NCT01261338

Intervention to Reduce Body Burdens of PCBs in Residents of Anniston, Alabama

NCT01261338 ↗

RandomizedParallel-groupDouble-blindBasic science

Summary

Because of industrial pollution, a large number of people in Anniston, Alabama, have elevated body burdens of the class of compounds known as polychlorinated biphenyls (PCBs). There is evidence that these compounds are associated with risks to health including diabetes. There is also evidence that the consumption of a non-absorbable dietary fat can reduce the level of compounds like PCBs. This clinical trial will test the hypothesis that a non-absorbable dietary fat can reduce the levels of PCBs in subjects in Anniston.

Timeline

Start
2010-12
Primary completion
2012-04
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject olestra Unknown 15 g —